相关实验视频
Updated: Sep 15, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.6K
精神分裂症管理:当前药物和第三阶段药物的系统审查 (2008-2024)
Salma Abdelmoteleb1, Jayant Totlani2, Salma Ramadan1,3
1Cedars-Sinai Health System, Los Angeles, CA, USA.
Neuroscience applied
|July 14, 2025
概括
本综述详细介绍了2008年至2024年期间批准的治疗精神分裂症的精神病药物,并指出29项FDA批准,其中包括13种长效注射剂 (LAI). 新的治疗方法和管道药物显示出改善精神分裂症护理患者结果的希望.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 神经科学是一个神经科学.
- 药物开发 药物开发
背景情况:
- 随着新的药物疗法,精神分裂症的治疗已经发生了显著的进化.
- 对精神病药物的监管批准和区域可用性各不相同.
- 长效注射剂 (LAI) 配方为口服抗精神病药物提供了替代品.
研究的目的:
- 系统地审查2008年至2024年间批准的治疗精神分裂症的精神病药物.
- 分析美国,欧洲和亚洲的监管实践和药物批准.
- 详细介绍这些治疗方法的作用机制,说明,疗效,剂量和不良影响.
主要方法:
- 在PubMed (2008-2024) 的系统文献搜索中,使用与精神分裂症和精神药理学相关的关键词.
- 包括FDA批准和第三阶段管道中的药物,以及欧洲批准的药物.
- 独立评估和就符合审查条件的研究达成共识.
主要成果:
- 美国食品和药物管理局批准用于治疗精神分裂症的29种药物,其中包括13种LAI.
- 另外三种药物在欧洲获得批准,但在美国没有.
- 在第三阶段试验中的八种管道药物,包括一个LAI.
- 介绍了与药物相关的运动障碍的新疗法.
- 对每个药物的机制,说明,疗效,剂量和不良影响的分析.
结论:
- 批准的精神分裂症药物,特别是LAI显著增加,扩大治疗选择.
- 新兴的管道药物具有新的机制和注射途径,预示着未来的进步.
- 这些进展预计将加强治疗策略,改善精神分裂症管理中的患者结果.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
212
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
212
01:28Psychosis and Antipsychotic Drugs: Overview
463
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
463
01:28Drug Therapy
105
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
105
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
390
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
390
01:21Antipsychotic Drugs: Typical and Atypical Agents
326
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
326
01:24Mania and Antimanic Drugs: Overview
323
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
323